This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Elsevier organizes label-free technologies conference

April 5th, 2012

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the Label-Free Technologies Conference to be held in Amsterdam, the Netherlands, 1-3 November 2012.

Organized by Elsevier in association with Horiba Scientific, Label-Free Technologies will be a two-day conference entirely dedicated to bringing together the latest research on the advances and application of label-free technology in pharmacology and drug discovery.

The conference, chaired by Professor Evi Kostenis, University of Bonn, Germany and Professor Anthony (Tony) Turner, Linköping University, Sweden, will focus on three themes; state of the art, new applications of currently available instruments and emerging technologies.

"Label-free technologies have made enormous progress in recent years and have generated wealth well beyond the simple sales figures associated with the instruments themselves, by enabling drug development and research in the life sciences. It is now timely to review this emerging subject area and to consolidate the advanced applications now available while looking to the future for what will become available," said conference Co-Chair Professor Turner.

Elsevier's journals Drug Discovery Today and Biosensors & Bioelectronics are the supporting publications for the conference.

Abstracts for oral and poster presentations are invited.

More information including invited speakers available at: http://www.labelfreetech.com

Provided by Elsevier

Citation: Elsevier organizes label-free technologies conference (2012, April 5) retrieved 7 August 2026 from https://sciencex.com/wire-news/95073738/elsevier-organizes-label-free-technologies-conference.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.